RM Partners has developed a robust governance structure to oversee transformation work. This structure provides effective leadership and direction across all elements of our transformational activity.

Key strategic decisions are taken to the RM Partners Executive Board for approval. Membership of this group includes Chief Executive Officers from our acute provider organisations, STP leads, and a specialised commissioning representative.

Currently, each member of the Executive Board currently has formal accountability to their individual provider/commissioner organisation boards. However, we would expect this to change as we implement a lead provider model, as per our vanguard delivery plan.

Underpinning the Executive Board is our Clinical Oversight Group, which provides clinical opinion on transformation activities and advises on setting clinical priorities; our Patient Advisory Board, which provides patient opinion on transformation activities and advises on setting patient engagement priorities; and  a Delivery Group, which is responsible for operational delivery of the transformation projects.